We do not earn a commission from this provider.
Rylo Health review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Rylo Health charges $139 a month for compounded semaglutide billed monthly, or $100 a month billed $299 quarterly. Both rates sit on the same screen with the total.
The $100 is the quarterly rate, billed $299 every three months. The monthly rate is $139 and sits directly beside it on the semaglutide page.
- Advertised $100, actually $139
- Month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
Monthly and quarterly side by side, dose-independent, no membership fee. Two GLP-1s and nothing else priced.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Semaglutide, billed monthly
- $139
- Semaglutide, quarterly
- $100 a month, $299 billed
- Tirzepatide, billed monthly
- $229
- Tirzepatide, quarterly
- $160 a month, $479 billed
- Price by dose?
- No. Same price at every dose
- Membership fee
- None, stated beside the price
- States served
- Not published on any page we read
Pros and cons
What we like
- Monthly and quarterly rates are on the same screen, each with the amount actually billed.
- "Same price at every dose" and "No membership fee" sit beside the figures, not in a footnote.
- The compounded disclaimer is printed in full on both drug pages, including the pregnancy contraindication.
- The terms name the company and a Texas street address, which let us run the FDA entity screen.
What could be better
- NAD+ is listed as a product on the homepage and priced on no page we read.
- No term longer than three months is offered or priced.
- The homepage leads with the quarterly rate as a "from" price without naming the term in the same line.
- No state list appears on any of the four pages we read.
What it is
A two-drug compounded GLP-1 service, sold on flat pricing and a US compounding pharmacy, with no membership layer. The homepage lists NAD+ as a third product but does not price it on any page we read.
Both drug pages print the compounded disclaimer in full, including that the FDA does not evaluate compounded drugs for safety, effectiveness or quality — the difference between a compounded vial and an approved pen.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, billed monthlyCharged monthly. The $100 is the quarterly rate. | $100 | $139 | September 2026 | |
| Compounded semaglutide, quarterly$299 billed every three months. | not published | $100 | not comparable | September 2026 |
| Compounded tirzepatide, billed monthlyCharged monthly. The $160 is the quarterly rate. | $160 | $229 | September 2026 | |
| Compounded tirzepatide, quarterly$479 billed every three months. | not published | $160 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
Semaglutide is $139 a month billed monthly, or $100 a month billed $299 every three months. Tirzepatide is $229 monthly, or $160 a month billed $479. Both terms are on screen at once with the totals printed.
Each page also states "Same price at every dose" and "No membership fee" beside the figures rather than in a footnote, which is where those claims usually live when they live anywhere.
The homepage leads with "From $100 a month", which is the quarterly rate. That is the standard move, but here the monthly figure is one click away on the drug's own page and is not hidden behind a control — unlike a seller whose standard rate renders only after a tab is clicked.
Who it's wrong for
- Skip it if you want a peptide priced. NAD+ is listed as a product and carries no figure anywhere we read.
- Skip it if you want longer than three months. No six- or twelve-month rate is published.
- Skip it if your state matters. No list appears on any of the four pages we read, and we count who publishes one at all.
Medications available
- Compounded semaglutideCompounded$139 monthly, or $100 a month billed quarterly
Once-weekly injection, same price at every dose, no membership fee.
- Compounded tirzepatideCompounded$229 monthly, or $160 a month billed quarterly
Once-weekly, same structure.
Is Rylo Health legit?
Rylo Health is operated by Rylo Health LLC, 1708 Spring Green Blvd, Katy, TX 77494. We read that off the company’s own terms of service on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Who prescribesA US-licensed physician, stated beside the price on both drug pages
- PharmacyDescribed as a US compounding pharmacy, not named
- Compounded disclosureFull, including the pregnancy contraindication
- Membership feeNone, stated beside the price
- States servedNot published
Common questions
What is Rylo Health's month-to-month price?
$139 a month for compounded semaglutide and $229 for compounded tirzepatide. Both figures sit beside the quarterly alternative on the drug's own page rather than behind a control.
How much is the quarterly plan?
Semaglutide works out to $100 a month, billed $299 every three months. Tirzepatide is $160 a month, billed $479. Both totals are printed next to the per-month figure.
Does the price rise with the dose?
No. Both drug pages state the same price applies at every dose, and neither carries a dose ladder or a titration surcharge anywhere we could find on the pages we read.
Why we gave Rylo Health a B
Read the full grading rationale
Both terms are on screen at once, labeled Monthly and Quarterly, with the quarterly total spelled out: semaglutide $139 a month or $100 a month billed $299 every three months; tirzepatide $229 or $160 billed $479. Each page also states 'Same price at every dose' and 'No membership fee' beside the figures rather than in a footnote, and prints the compounded-medication disclaimer in full. The homepage advertises 'From $100 a month', which is the quarterly rate — the standard trick — but here the month-to-month number is one click away on the drug's own page and is not hidden behind a control. What keeps it from an A is that nothing beyond the two GLP-1s is priced: the homepage lists NAD+ as a product and no page read carries a figure for it. The terms name Rylo Health LLC and a Katy, Texas street address. FDA warning-letter screen by domain and address: 0 of 0 matched, both controls passing in the same run. No state list on the four pages read.
How we reviewed Rylo Health
- We read both drug pages, the homepage and the terms of service first-hand at desktop width.
- Each figure is captured from the page it appears on, with the quarterly total quoted verbatim beside the per-month equivalent.
- The FDA warning-letter screen was run against the domain and the Katy address in the terms, with a known-positive and a known-negative control passing in the same run.
The 2 pages we read — all on
- Semaglutide page
Monthly $139/mo Save $118 Quarterly $100/mo
- Tirzepatide page
Monthly $229/mo Save $208 Quarterly $160/mo
This link pays us nothing. It's here because the price is checkable.
Alternatives to Rylo Health
| Provider | Grade | Cheapest price |
|---|---|---|
| Open Water Rx | BMinor gap | $109/mo |
| Obu Health | BMinor gap | $149/mo |
| Fierce Health | CCaveat | $100/mo |
| Alternate Health Club | CCaveat | $99/mo |
| Cora Health | BMinor gap | $99/mo |